薬局管理システムの2030年までの市場予測

Pharmacy Management System Market Forecast to 2030

薬局管理システムの2030年までの市場予測市場動向薬局管理システム市場は、2030年までに10.12%という健全なCAGRを記録すると予想されています。薬局で利用され、薬局の作業プロセスのコンピュータ化を支... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Market Research Future マーケットリサーチフューチャー (MRFR)	2023年3月7日	US$7,250 ライセンス・価格情報注文方法はこちら	110	英語

目次
図表リスト

サマリー

薬局管理システムの2030年までの市場予測

市場動向

薬局管理システム市場は、2030年までに10.12%という健全なCAGRを記録すると予想されています。薬局で利用され、薬局の作業プロセスのコンピュータ化を支援するシステムは、薬局管理プログラミングとして知られています。これは、医師の薬の評価や薬の準備、在庫管理などが含まれます。薬局管理システムの世界的な市場発展は、薬局管理システムに関連する重要なドライブや利点の数の上昇、および治療薬の数の増加による薬剤専門家の負担に起因しています。また、新興国での薬局管理システムに対する関心の高まりは、今後、市場に学習効果をもたらします。しかし、ベンダーのセキュリティなど、複雑な問題があるため、予測期間中に市場の発展が妨げられる可能性があります。
薬局管理システムは、非常に強力でユーザーフレンドリーな管理機能を備えた巨大な装置であり、在庫管理、処方箋の管理、取引機能などの業務を監督する上で、薬剤専門家を支援します。また、これらのシステムにより、薬剤師の方々は、患者さんのニーズに合わせて十分な配慮ができるようになります。派遣、統合や買収、協調的な取り組み、共同努力など、重要なドライブの数が増加していることが、薬局管理システム市場を牽引しています。
セグメント別概要
ソリューションタイプ別では、薬局在庫管理ソフトウェア、薬局情報管理システム、薬局強化ソフトウェアシステム、薬局アドバンテージ管理、薬局収入サイクル管理システム、その他に分類されます。
コンポーネント別では、ソフトウェア、ハードウェア、サービスに分類されます。導入形態別では、オンプレミス型とクラウド/電子型に分類されます。エンドユーザー別では、「継続型ドラッグストア」と「短期型ドラッグストア」に分類されます。短期市場については、さらにクイックトラックセンターと救急クリニックに細分化される。
地域別分析
アメリカは、2030年末までに10.29%という大きなCAGRを記録すると予想されています。これは、例えば、バーンスルーの減少を支援し、スタッフの時間を節約する機械化された終了日のフォローなど、機械的な進歩の拡大に起因するものである。American School of Clinical Pharmacyによると、2021年までに約50億の治療薬が割り当てられ、薬剤師の体重が増加するため、作業工程管理における機械化の受け入れは普通である。
欧州の薬局管理システム市場は、フランス、ドイツ、英国、スイス、オランダ、ベルギー、ロシア、スペイン、イタリア、オーストリア、および欧州の残りの部分に分離されます。薬局管理システムによってもたらされる利点は、薬の専門家がPCや携帯電話から、有利で煩わしいことなく薬を監督できるようにすることです。さらに、地域全体のウェブ普及率の上昇、医療行政のデジタル化のさらなる進展、教育を受けた薬剤師の数の増加が、市場発展を後押ししています。
主要プレーヤー
DataScan Pharmacy（米国）、Cerner Corporation（米国）、Allscripts Healthcare, LLC（米国）、Epicor Software Corporation（米国） GlobeMed Group（レバノン）、LS Retail EHF（アイスランド）、McKesson Corporation（米国）、Liberty Software, Inc.(米国）、MedHOK, Inc.（米国）、Octal IT Solution LLP（インド）、ScriptPro LLC（米国）、Clanwilliam Health（アイルランド）、Safecare Technology（UAE）、Mobile MedSoft（米国）、ヘルスビジネスシステム社（米国）です。

ページTOPに戻る

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE SYSTEM

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 RISE IN THE NUMBER OF STRATEGIC INITIATIVES

4.2.2 BENEFITS ASSOCIATED WITH PHARMACY MANAGEMENT SYSTEMS

4.2.3 BURDEN ON PHARMACISTS DUE TO INCREASING NUMBER OF PRESCRIPTIONS

4.3 RESTRAINTS

4.3.1 COMPLEX FEATURES SUCH AS VENDOR LOCK-IN

4.4 OPPORTUNITIES

4.4.1 INCREASING DEMAND FOR PHARMACY MANAGEMENT SYSTEMS IN EMERGING ECONOMIES

4.5 CHALLENGES

4.5.1 UNAVAILABILITY OF TRAINED PROFESSIONALS

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 INPUTS

5.1.2 SOFTWARE DEVELOPMENT PROCESSES

5.1.3 OUTPUT

5.1.4 MARKETING AND DISTRIBUTION

5.1.5 POST-SELLING SERVICES

5.1.5.1 SOFTWARE MAINTENANCE SERVICES & AGREEMENTS

5.1.5.2 TRAINING & CERTIFICATIONS

5.1.5.3 SUPPORT: TECHNICAL & GRIEVANCE AID

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE PHARMACY MANAGEMENT SYSTEM MARKET

6 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE

6.1 OVERVIEW

6.2 PHARMACY INVENTORY MANAGEMENT SYSTEM

6.3 PHARMACY DATA MANAGEMENT SYSTEM

6.4 PHARMACY COMPOUNDING SOFTWARE SYSTEM

6.5 PHARMACY BENEFITS MANAGEMENT SYSTEM

6.6 PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM

6.7 OTHERS

7 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT

7.1 OVERVIEW

7.2 SOFTWARE

7.3 HARDWARE

7.4 SERVICES

8 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE

8.1 OVERVIEW

8.2 CLOUD/WEB-BASED

8.3 ON-PREMISE

9 GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER

9.1 OVERVIEW

9.2 INPATIENT PHARMACIES

9.3 OUTPATIENT PHARMACIES

10 PHARMACY MANAGEMENT SYSTEMS, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 NETHERLANDS

10.3.1.7 SWITZERLAND

10.3.1.8 BELGIUM

10.3.1.9 AUSTRIA

10.3.1.10 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 JAPAN

10.4.2 CHINA

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 TAIWAN

10.4.7 NEW ZEALAND

10.4.8 THAILAND

10.4.9 PHILIPPINES

10.4.10 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11.6.2 MERGER & ACQUISITIONS

11.6.3 AGREEMENT/MARKETING STRATEGIES

12 COMPANY PROFILES

12.1 ALLSCRIPTS HEALTHCARE, LLC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 CERNER CORPORATION

12.2.1 COMPANY OVERVIEW

12.2.2 PRODUCTS OFFERED

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 DATASCAN PHARMACY

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 KEY STRATEGIES

12.4 EPICOR SOFTWARE CORPORATION

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 GLOBEMED GROUP

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 LIBERTY SOFTWARE, INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 LS RETAIL EHF

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 KEY STRATEGIES

12.8 MCKESSON CORPORATION

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 MEDHOK, INC.

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 KEY STRATEGIES

12.10 OCTAL IT SOLUTION LLP

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

12.11 SAFECARE TECHNOLOGY

12.11.1 COMPANY OVERVIEW

12.11.2 FINANCIAL OVERVIEW

12.11.3 PRODUCTS OFFERED

12.11.4 KEY DEVELOPMENTS

12.11.5 KEY STRATEGIES

12.12 SCRIPTPRO LLC

12.12.1 COMPANY OVERVIEW

12.12.2 FINANCIAL OVERVIEW

12.12.3 PRODUCTS OFFERED

12.12.4 KEY DEVELOPMENTS

12.12.5 KEY STRATEGIES

12.13 CLANWILLIAM HEALTH

12.13.1 COMPANY OVERVIEW

12.13.2 FINANCIAL OVERVIEW

12.13.3 PRODUCTS OFFERED

12.13.4 KEY DEVELOPMENTS

12.13.5 KEY STRATEGIES

12.14 MOBILE MEDSOFT

12.14.1 COMPANY OVERVIEW

12.14.2 FINANCIAL OVERVIEW

12.14.3 PRODUCTS OFFERED

12.14.4 KEY DEVELOPMENTS

12.14.5 KEY STRATEGIES

12.15 HEALTH BUSINESS SYSTEMS, INC.

12.15.1 COMPANY OVERVIEW

12.15.2 FINANCIAL OVERVIEW

12.15.3 PRODUCTS OFFERED

12.15.4 KEY DEVELOPMENTS

12.15.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS

ページTOPに戻る

図表リスト

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 4 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY INVENTORY MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY DATA MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY COMPOUNDING SOFTWARE SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMA PHARMACY BENEFITS MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR PHARMACY REVENUE CYCLE MANAGEMENT SYSTEM, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 10 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, FOR SERVICES, BY REGION, 2018–2030 (USD MILLION)

TABLE 14 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 15 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR CLOUD/WEB-BASED, BY REGION, 2018–2030 (USD MILLION)

TABLE 16 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR ON-PREMISE, BY REGION, 2018–2030 (USD MILLION)

TABLE 17 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 18 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY REGION, 2018–2030 (USD MILLION)

TABLE 19 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2018–2030 (USD MILLION)

TABLE 20 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY REGION, 2018–2030 (USD MILLION)

TABLE 21 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2018–2030 (USD MILLION)

TABLE 22 GLOBAL: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 23 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 24 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 25 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 26 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 27 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 28 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 29 AMERICAS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 30 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 31 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 32 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 33 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 34 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 35 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 36 NORTH AMERICA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 37 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 38 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 39 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 40 US: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 41 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 42 US: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 43 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 44 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 45 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 46 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 47 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 48 CANADA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 49 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 50 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 51 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 52 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 53 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 54 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 55 EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 56 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 57 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 58 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 59 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 60 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 61 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 62 WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 63 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 64 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 65 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 66 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 67 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 68 GERMANY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 69 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 70 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 71 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 72 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 73 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 74 FRANCE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 75 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 76 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 77 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 78 UK: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 79 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 80 UK: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 81 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 82 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 83 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 84 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 85 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 86 ITALY: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 87 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 88 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 89 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 90 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 91 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 92 SPAIN: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 93 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 94 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 95 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 96 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 97 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 98 NETHERLANDS: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 99 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 100 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 101 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 102 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 103 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 104 SWITZERLAND: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 105 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 106 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 107 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 108 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 109 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 110 BELGIUM: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 111 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 112 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 113 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 114 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 115 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 116 AUSTRIA: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 117 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 118 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 119 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 120 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 121 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 122 REST OF WESTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 123 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 124 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR SERVICES, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 125 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 126 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET, BY END USER, 2018–2030 (USD MILLION)

TABLE 127 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR INPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 128 EASTERN EUROPE: PHARMACY MANAGEMENT SYSTEM MARKET FOR OUTPATIENT PHARMACIES, BY END USER, 2018–2030 (USD MILLION)

TABLE 129 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 130 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 131 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 132 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 133 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 134 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 135 ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 136 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 137 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 138 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 139 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 140 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 141 JAPAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 142 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 143 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 144 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 145 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 146 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 147 CHINA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 148 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 149 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 150 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 151 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 152 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 153 INDIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 154 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 155 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 156 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 157 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 158 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 159 AUSTRALIA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 160 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 161 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 162 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 163 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 164 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 165 SOUTH KOREA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 166 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 167 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 168 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 169 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 170 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 171 TAIWAN: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 172 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 173 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 174 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 175 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 176 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 177 NEW ZEALAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 178 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 179 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 180 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 181 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 182 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 183 THAILAND: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 184 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 185 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 186 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 187 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 188 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 189 PHILIPPINES: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 190 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 191 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 192 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 193 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 194 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 195 REST OF ASIA-PACIFIC: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 196 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 197 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 198 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 199 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 200 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 201 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 202 MIDDLE EAST & AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 203 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 204 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 205 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 206 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 207 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 208 MIDDLE EAST: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 209 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY SOLUTION TYPE, 2018–2030 (USD MILLION)

TABLE 210 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY COMPONENT, 2018–2030 (USD MILLION)

TABLE 211 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY DEPLOYMENT MODE, 2018–2030 (USD MILLION)

TABLE 212 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY END USER, 2018–2030 (USD MILLION)

TABLE 213 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY INPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 214 AFRICA: PHARMACY MANAGEMENT SYSTEMS, BY OUTPATIENT PHARMACIES, 2018–2030 (USD MILLION)

TABLE 215 MAJOR PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET

TABLE 216 MOST ACTIVE PLAYERS IN THE GLOBAL PHARMACY MANAGEMENT SYSTEM MARKET

TABLE 217 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 218 MERGER & ACQUISITIONS

TABLE 219 AGREEMENT/MARKETING STRATEGIES

TABLE 220 ALLSCRIPTS HEALTHCARE, LLC: SERVICES OFFERED

TABLE 221 ALLSCRIPTS HEALTHCARE, LLC: KEY DEVELOPMENTS

TABLE 222 CERNER CORPORATION: PRODUCTS OFFERED

TABLE 223 DATASCAN PHARMACY: PRODUCTS OFFERED

TABLE 224 EPICOR SOFTWARE CORPORATION: PRODUCTS OFFERED

TABLE 225 GLOBEMED GROUP: PRODUCTS OFFERED

TABLE 226 LIBERTY SOFTWARE, INC.: PRODUCTS OFFERED

TABLE 227 LS RETAIL EHF.: PRODUCTS OFFERED

TABLE 228 MCKESSON CORPORATION: PRODUCTS OFFERED

TABLE 229 MCKESSON CORPORATION: KEY DEVELOPMENTS

TABLE 230 MEDHOK, INC.: PRODUCTS OFFERED

TABLE 231 OCTAL IT SOLUTION LLP.: PRODUCTS OFFERED

TABLE 232 SAFECARE TECHNOLOGY: PRODUCTS OFFERED

TABLE 233 SCRIPTPRO LLC: PRODUCTS OFFERED

TABLE 234 CLANWILLIAM HEALTH: PRODUCTS OFFERED

TABLE 235 CLANWILLIAM HEALTH: KEY DEVELOPMENTS

TABLE 236 MOBILE MEDSOFT: PRODUCTS OFFERED

TABLE 237 HEALTHCARE BUSINESS SYSTEMS, INC.: PRODUCTS OFFERED

ページTOPに戻る

Table of Contents
List of Tables/Graphs

Summary

Pharmacy Management System Market Forecast to 2030

Market Dynamics

The pharmacy management system market is expected to register a healthy CAGR of 10.12% by 2030. The system utilized in a pharmacy to assist with computerizing the pharmacy work process is known as pharmacy management programming. This incorporates assessing doctor medicines and getting ready meds, and stock management. The worldwide market development of the pharmacy management system is credited to the ascent in the number of vital drives, and benefits related to pharmacy management systems, and the weight on drug specialists because of the rising number of remedies. Besides, the rising interest in pharmacy management systems in arising economies gives learning experiences to the market from now on. Notwithstanding, complex highlights, for example, vendor security could obstruct the market's development in the conjecture period.
Pharmacy management systems are huge devices with exceptionally powerful and user-friendly management benefits that help drug specialists in overseeing assignments, including stock management, administering prescriptions, and deals capability. These systems additionally permit drug specialists to offer proficient consideration in light of patient necessities. A rising number of vital drives as dispatches, consolidations and acquisitions, coordinated efforts, and joint endeavors are driving the pharmacy management system market.
Segment Overview
By Solution Type, the market is partitioned into Pharmacy Stock Management Software, Pharmacy Information Management Systems, Pharmacy Intensifying Software Systems, Pharmacy Advantage Management, Pharmacy Income Cycle Management System, and Others.
By Component, the fragment separates the market into Software, Hardware, and Services. By Deployment Mode the market is bifurcated into On-Premises and Cloud/Electronic. By End Users, the worldwide market is bifurcated into Ongoing Drug stores and short-term Drug stores. The short-term fragment is further sub-sectioned into quick track centers and emergency clinic retail settings.
Regional Analysis
Americas is expected to register a significant CAGR of 10.29% by the end of 2030. This is credited to expanding mechanical headway, for example, mechanized termination date following, which assists with lessening burn through and saves staff time and so on. As per the American School of Clinical Pharmacy, around 5 billion remedies will be apportioned by 2021, which will build drug specialists' weight; thus, the reception of mechanized arrangements in work process management is normal.
The Europe pharmacy management system market is segregated among France, Germany, the UK, Switzerland, Netherlands, Belgium, Russia, Spain, Italy, Austria, and the remainder of Europe. The advantages presented by pharmacy management empower drug specialists to oversee medication advantageously and bother-free, right from their PC or cell phone. Moreover, rising web infiltration across the region, further developing digitalization of medical care administrations, and the developing number of educated drug specialists are additionally supporting the market development.
Key Players
DataScan Pharmacy (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Epicor Software Corporation (US) GlobeMed Group (Lebanon), LS Retail EHF (Iceland), McKesson Corporation (US), Liberty Software, Inc. (US), MedHOK, Inc. (US), Octal IT Solution LLP (India), ScriptPro LLC (US), Clanwilliam Health (Ireland), Safecare Technology (UAE), Mobile MedSoft (US), and Health Business Systems, Inc. (US).

ページTOPに戻る

List of Tables/Graphs

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Market Research Future社はどのような調査会社ですか?

マーケットリサーチフューチャー（Market Research Future）は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。下記分野については、分野毎に専... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

薬局管理システムの2030年までの市場予測

サマリー

目次

図表リスト

Summary

Table of Contents

List of Tables/Graphs

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Market Research Future社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?